(Q33416427)

English

Front-line transplantation program with lenalidomide, bortezomib, and dexamethasone combination as induction and consolidation followed by lenalidomide maintenance in patients with multiple myeloma: a phase II study by the Intergroupe Francophone du

scientific article published on 14 July 2014

Statements

Front-line transplantation program with lenalidomide, bortezomib, and dexamethasone combination as induction and consolidation followed by lenalidomide maintenance in patients with multiple myeloma: a phase II study by the Intergroupe Francophone du (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
Valérie Lauwers-Cances
Denis Caillot
Catherine Gentil
2712-2717

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit